Video | 04 April 2022 Why we’re asking governments to reject the leaked text on COVID-19 at the WTO COVID-19 Leena Menghaney outlines why the leaked TRIPS Waiver doesn't go anywhere near far enough in terms of addressing the development of COVID-19 treatments, vaccines and diagnostics. Read, watch, share Filter by - Any -BlogEventsExplainerFeature storyInterviewIssue briefLetterNewsletterOpinion articlePress releaseSpeechSpotlightStatementTechnical briefVideo Photograph by Pierre Fromentin Press release Press release | 22 February 2022 COVID-19 Landmark ‘TRIPS Waiver’ must be agreed now: no time to lose 5 min Photograph by MSF Press release Press release | 18 February 2022 COVID-19 Africa MSF responds to WHO announcement that 6 countries will receive tech from mRNA COVID-19 hub 4 min Letter | 16 February 2022 COVID-19 Civil society open letter to the WTO Director General Blog Blog | 12 February 2022 COVID-19 COVAX — A broken promise for vaccine equity Technical brief | 28 January 2022 COVID-19 South Africa Removing intellectual-property barriers from COVID-19 vaccines and treatments for people in South Africa Photograph by Nikhil Roshan Press release Press release | 14 January 2022 COVID-19 MSF responds to latest WHO recommendation for a COVID-19 therapeutic, baricitinib 3 min Photograph by Pierre Fromentin Press release Press release | 23 December 2021 COVID-19 MSF responds to FDA approval of COVID-19 drug molnupiravir 3 min Photograph by Chris Allan Press release Press release | 22 December 2021 COVID-19 MSF responds to FDA approval of COVID-19 treatment nirmatrelvir/ritonavir 5 min Load More
Photograph by Pierre Fromentin Press release Press release | 22 February 2022 COVID-19 Landmark ‘TRIPS Waiver’ must be agreed now: no time to lose 5 min
Photograph by MSF Press release Press release | 18 February 2022 COVID-19 Africa MSF responds to WHO announcement that 6 countries will receive tech from mRNA COVID-19 hub 4 min
Technical brief | 28 January 2022 COVID-19 South Africa Removing intellectual-property barriers from COVID-19 vaccines and treatments for people in South Africa
Photograph by Nikhil Roshan Press release Press release | 14 January 2022 COVID-19 MSF responds to latest WHO recommendation for a COVID-19 therapeutic, baricitinib 3 min
Photograph by Pierre Fromentin Press release Press release | 23 December 2021 COVID-19 MSF responds to FDA approval of COVID-19 drug molnupiravir 3 min
Photograph by Chris Allan Press release Press release | 22 December 2021 COVID-19 MSF responds to FDA approval of COVID-19 treatment nirmatrelvir/ritonavir 5 min
